Semin Perinatol. 2019 Jul 30:151166. doi: 10.1053/j.semperi.2019.07.005. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/31472951
The role of ECMO in the management of congenital diaphragmatic hernia.
Yu PT1, Jen HC2, Rice-Townsend S3, Guner YS4.
Author information
1Division of Pediatric Surgery, Children’s Hospital of Orange County, Orange, CA, United States; Department of Surgery, University of California Irvine Medical Center, 505 S. Main St, #225, Orange, CA 92868, United States.2David Geffen School of Medicine at UCLA, Mattel Children’s Hospital at UCLA, Los Angeles, CA, United States.3Department of Pediatric Surgery, Children’s Hospital Boston-Harvard Medical School, Boston, MA, United States.4Division of Pediatric Surgery, Children’s Hospital of Orange County, Orange, CA, United States; Department of Surgery, University of California Irvine Medical Center, 505 S. Main St, #225, Orange, CA 92868, United States. Electronic address: yguner@uci.edu.
Abstract
Congenital diaphragmatic hernia (CDH) is the most common indication for extra-corporeal membrane oxygenation (ECMO) for neonatal respiratory failure. CDH management is evolving with advanced prenatal diagnostic imaging modalities. The risk profiles of infants receiving ECMO for CDH are shifting towards higher risk. Many clinicians are developing and following clinical practice guidelines to standardize and optimize the care of CDH neonates. Despite these efforts, there are significant differences in the practice patterns among ECMO centers as to how and when they choose to initiate ECMO for CDH, when they believe repair is safe, as well as many other nuances that are based on center experience or style. The purpose of this report is to summarize our current understanding of the new and recent developments regarding management of infants with CDH managed with ECMO.
Copyright © 2019 Elsevier Inc. All rights reserved.
KEYWORDS:
CDH; ECMO; HerniaPMID: 31472951 DOI: 10.1053/j.semperi.2019.07.005
